Since the courts have long held that products of nature are patentable once isolated or manipulated by man, the District Court decision of Judge Sweet in the "Myriad" case that isolated or manipulated genes are not patentable and the subsequent appeal of that decision to the Court of Appeals for the Federal Circuit (CAFC) has prompted considerable legal debate.